Insider trades
Dipal Doshi, CEO of Entrada Therapeutics TRDA, has filed 0 purchases and 19 sales on the open market. The latest trade was on 03/03.
Dipal Doshi
CEO
- Company
- Entrada Therapeutics TRDA
- First filing
- 23/03/29
- Trades
- 47 trades
- Buys / sales
- 0 / 19
- 12-month net buying
- No record
- Last trade
- 03/03
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
TRDA | Open-market sale10b5-1 plan | 24/07/12–24/07/15 | 24/07/16 | 1,900 sh2 trades | $17.84avg. | $33,896 | −0.6% |
| Open-market sale10b5-1 plan | 24/06/13 | 24/06/14 | 1,000 sh | $16.17 | $16,170 | −0.3% | |
TRDA | Open-market sale10b5-1 plan | 24/05/16–24/05/17 | 24/05/20 | 3,000 sh2 trades | $15.04avg. | $45,132 | −0.9% |
| Open-market sale10b5-1 plan | 24/02/15 | 24/02/20 | 1,000 sh | $15.00 | $15,000 | −0.4% | |
| Open-market sale10b5-1 plan | 24/01/16 | 24/01/18 | 1,000 sh | $15.99 | $15,990 | −0.4% | |
| Open-market sale10b5-1 plan | 23/12/20 | 23/12/22 | 1,000 sh | $15.00 | $15,000 | −0.4% | |
| Open-market sale10b5-1 plan | 23/11/13 | 23/11/13 | 1,000 sh | $16.23 | $16,230 | −0.4% | |
| Open-market sale10b5-1 plan | 23/10/17 | 23/10/19 | 1,000 sh | $15.00 | $15,000 | −0.4% | |
| Open-market sale10b5-1 plan | 23/09/13 | 23/09/15 | 1,000 sh | $15.00 | $15,000 | −0.4% | |
| Open-market sale10b5-1 plan | 23/08/14 | 23/08/16 | 1,000 sh | $15.67 | $15,670 | −0.5% | |
| Open-market sale10b5-1 plan | 23/04/27 | 23/05/01 | 2,000 sh | $13.71 | $27,420 | −1.0% | |
| Open-market sale10b5-1 plan | 23/04/17 | 23/04/19 | 2,092 sh | $18.01 | $37,676.92 | −1.0% | |
TRDA | Open-market sale10b5-1 plan | 23/03/27 | 23/03/29 | 2,000 sh2 trades | $14.72avg. | $29,436 | −0.8% |
| Open-market sale | 23/02/28 | 23/03/02 | 2,000 sh | $12.00 | $24,000 | −1.2% | |
| Open-market sale | 23/01/27 | 23/01/30 | 2,000 sh | $12.00 | $24,000 | −1.2% | |
| Open-market sale | 23/01/09 | 23/01/10 | 2,410 sh | $15.02 | $36,198.2 | −1.4% |